nodes	percent_of_prediction	percent_of_DWPC	metapath
Acepromazine—ALB—Crohn's disease	0.86	1	CbGaD
Acepromazine—HTR2A—enteric nervous system—Crohn's disease	0.0059	0.397	CbGeAlD
Acepromazine—HTR2A—myenteric nerve plexus—Crohn's disease	0.00447	0.301	CbGeAlD
Acepromazine—ALB—gall bladder—Crohn's disease	0.00167	0.113	CbGeAlD
Acepromazine—Desipramine—SLC22A4—Crohn's disease	0.000972	0.248	CrCbGaD
Acepromazine—Imipramine—SLC22A4—Crohn's disease	0.000824	0.211	CrCbGaD
Acepromazine—Desipramine—SLC22A5—Crohn's disease	0.00073	0.187	CrCbGaD
Acepromazine—ADRA1A—epithelium—Crohn's disease	0.000688	0.0464	CbGeAlD
Acepromazine—ADRA1A—lymphoid tissue—Crohn's disease	0.00053	0.0357	CbGeAlD
Acepromazine—HTR2A—epithelium—Crohn's disease	0.000445	0.03	CbGeAlD
Acepromazine—HTR2A—smooth muscle tissue—Crohn's disease	0.000429	0.0289	CbGeAlD
Acepromazine—ALB—lymph node—Crohn's disease	0.000376	0.0253	CbGeAlD
Acepromazine—HTR2A—digestive system—Crohn's disease	0.000338	0.0228	CbGeAlD
Acepromazine—Thioproperazine—ALB—Crohn's disease	0.000324	0.0828	CrCbGaD
Acepromazine—Thiothixene—ALB—Crohn's disease	0.000318	0.0814	CrCbGaD
Acepromazine—Pipotiazine—ALB—Crohn's disease	0.000318	0.0814	CrCbGaD
Acepromazine—Clomipramine—ALB—Crohn's disease	0.000252	0.0644	CrCbGaD
Acepromazine—Chlorpromazine—ALB—Crohn's disease	0.000173	0.0441	CrCbGaD
Acepromazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.000103	0.000847	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—RSPO3—Crohn's disease	0.000102	0.000844	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—PTGER4—Crohn's disease	0.000102	0.00084	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—TAGAP—Crohn's disease	0.000101	0.000834	CbGpPWpGaD
Acepromazine—HTR1A—SIDS Susceptibility Pathways—TNF—Crohn's disease	9.97e-05	0.000822	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—CCR6—Crohn's disease	9.95e-05	0.000821	CbGpPWpGaD
Acepromazine—ALB—Folate Metabolism—IL6—Crohn's disease	9.93e-05	0.000819	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—TAGAP—Crohn's disease	9.91e-05	0.000817	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	9.82e-05	0.00081	CbGpPWpGaD
Acepromazine—ALB—Selenium Micronutrient Network—TNF—Crohn's disease	9.78e-05	0.000806	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—RSPO3—Crohn's disease	9.75e-05	0.000804	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—SEL1L—Crohn's disease	9.7e-05	0.0008	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—PTGER4—Crohn's disease	9.65e-05	0.000796	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—CCR6—Crohn's disease	9.62e-05	0.000794	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—GPR65—Crohn's disease	9.6e-05	0.000791	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—IL3—Crohn's disease	9.56e-05	0.000788	CbGpPWpGaD
Acepromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	9.54e-05	0.000787	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—CCR6—Crohn's disease	9.48e-05	0.000782	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—CCR6—Crohn's disease	9.47e-05	0.000781	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—CCR6—Crohn's disease	9.27e-05	0.000765	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—RASGRP1—Crohn's disease	9.24e-05	0.000762	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—SEL1L—Crohn's disease	9.24e-05	0.000762	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—PTGER4—Crohn's disease	9.19e-05	0.000758	CbGpPWpGaD
Acepromazine—DRD2—G alpha (i) signalling events—CXCL8—Crohn's disease	9.06e-05	0.000747	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—RSPO3—Crohn's disease	8.99e-05	0.000741	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CCR9—Crohn's disease	8.88e-05	0.000732	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—RSPO3—Crohn's disease	8.84e-05	0.000729	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—PTGER4—Crohn's disease	8.76e-05	0.000723	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—CCR6—Crohn's disease	8.74e-05	0.000721	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PLA2G4F—Crohn's disease	8.69e-05	0.000717	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—IL3—Crohn's disease	8.68e-05	0.000716	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—RSPO3—Crohn's disease	8.66e-05	0.000714	CbGpPWpGaD
Acepromazine—HTR2A—SIDS Susceptibility Pathways—TNF—Crohn's disease	8.61e-05	0.00071	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—FADS1—Crohn's disease	8.6e-05	0.00071	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—CCR6—Crohn's disease	8.6e-05	0.000709	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—SEL1L—Crohn's disease	8.52e-05	0.000703	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—PTGER4—Crohn's disease	8.47e-05	0.000699	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CCR9—Crohn's disease	8.45e-05	0.000697	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—CCR6—Crohn's disease	8.42e-05	0.000694	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—RASGRP1—Crohn's disease	8.39e-05	0.000692	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—SEL1L—Crohn's disease	8.38e-05	0.000691	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—PTGER4—Crohn's disease	8.34e-05	0.000688	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—PTGER4—Crohn's disease	8.34e-05	0.000687	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—ITGA4—Crohn's disease	8.27e-05	0.000682	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—GPR65—Crohn's disease	8.25e-05	0.000681	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—IL3—Crohn's disease	8.22e-05	0.000678	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—SEL1L—Crohn's disease	8.21e-05	0.000677	CbGpPWpGaD
Acepromazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	8.21e-05	0.000677	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—PTGER4—Crohn's disease	8.16e-05	0.000673	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—IL3—Crohn's disease	8.07e-05	0.000665	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—GPX4—Crohn's disease	8.06e-05	0.000664	CbGpPWpGaD
Acepromazine—HTR1A—SIDS Susceptibility Pathways—IL6—Crohn's disease	8.05e-05	0.000664	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—RASGRP1—Crohn's disease	7.95e-05	0.000656	CbGpPWpGaD
Acepromazine—ALB—Selenium Micronutrient Network—IL6—Crohn's disease	7.89e-05	0.000651	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—GPR65—Crohn's disease	7.86e-05	0.000648	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—IL3—Crohn's disease	7.83e-05	0.000646	CbGpPWpGaD
Acepromazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	7.82e-05	0.000645	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—RASGRP1—Crohn's disease	7.8e-05	0.000643	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CCR9—Crohn's disease	7.79e-05	0.000643	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—GCKR—Crohn's disease	7.78e-05	0.000642	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—PTGER4—Crohn's disease	7.69e-05	0.000634	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CCR9—Crohn's disease	7.67e-05	0.000632	CbGpPWpGaD
Acepromazine—DRD1—Circadian rythm related genes—IL6—Crohn's disease	7.64e-05	0.00063	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—RASGRP1—Crohn's disease	7.57e-05	0.000624	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—PTGER4—Crohn's disease	7.57e-05	0.000624	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CCR9—Crohn's disease	7.51e-05	0.000619	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—IL3—Crohn's disease	7.46e-05	0.000616	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—PTGER4—Crohn's disease	7.41e-05	0.000611	CbGpPWpGaD
Acepromazine—ALB—Metabolism—MTMR3—Crohn's disease	7.39e-05	0.000609	CbGpPWpGaD
Acepromazine—ALB—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	7.37e-05	0.000608	CbGpPWpGaD
Acepromazine—DRD1—GPCR ligand binding—CXCL8—Crohn's disease	7.27e-05	0.000599	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—GPR65—Crohn's disease	7.24e-05	0.000597	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—RASGRP1—Crohn's disease	7.22e-05	0.000595	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—IL3—Crohn's disease	7.22e-05	0.000595	CbGpPWpGaD
Acepromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	7.21e-05	0.000594	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—GPR65—Crohn's disease	7.13e-05	0.000588	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—IL3—Crohn's disease	7.11e-05	0.000586	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—IL3—Crohn's disease	7.1e-05	0.000586	CbGpPWpGaD
Acepromazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	7.09e-05	0.000585	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—GPR65—Crohn's disease	6.98e-05	0.000576	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—RASGRP1—Crohn's disease	6.98e-05	0.000576	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—IL3—Crohn's disease	6.95e-05	0.000573	CbGpPWpGaD
Acepromazine—HTR2A—SIDS Susceptibility Pathways—IL6—Crohn's disease	6.95e-05	0.000573	CbGpPWpGaD
Acepromazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	6.94e-05	0.000573	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—RASGRP1—Crohn's disease	6.87e-05	0.000567	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—RASGRP1—Crohn's disease	6.87e-05	0.000566	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CCR6—Crohn's disease	6.84e-05	0.000564	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—RASGRP1—Crohn's disease	6.72e-05	0.000555	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—IL2RA—Crohn's disease	6.7e-05	0.000552	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—IL3—Crohn's disease	6.55e-05	0.00054	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—IL3—Crohn's disease	6.45e-05	0.000532	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—RASGRP1—Crohn's disease	6.34e-05	0.000523	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—IL3—Crohn's disease	6.31e-05	0.000521	CbGpPWpGaD
Acepromazine—HTR1A—GPCR ligand binding—CXCL8—Crohn's disease	6.25e-05	0.000515	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—RASGRP1—Crohn's disease	6.24e-05	0.000514	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—RBX1—Crohn's disease	6.18e-05	0.00051	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—RASGRP1—Crohn's disease	6.11e-05	0.000504	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—IL2RA—Crohn's disease	6.08e-05	0.000501	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—PTGER4—Crohn's disease	6.02e-05	0.000496	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR ligand binding—CXCL8—Crohn's disease	5.95e-05	0.000491	CbGpPWpGaD
Acepromazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	5.93e-05	0.000489	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CCR6—Crohn's disease	5.88e-05	0.000485	CbGpPWpGaD
Acepromazine—DRD2—Circadian rythm related genes—IL6—Crohn's disease	5.77e-05	0.000476	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—IL2RA—Crohn's disease	5.76e-05	0.000475	CbGpPWpGaD
Acepromazine—ALB—Metabolism—FADS1—Crohn's disease	5.76e-05	0.000475	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—IL2RA—Crohn's disease	5.65e-05	0.000466	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CCR6—Crohn's disease	5.6e-05	0.000462	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—CXCL8—Crohn's disease	5.49e-05	0.000453	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—IL2RA—Crohn's disease	5.48e-05	0.000452	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—UBE2D1—Crohn's disease	5.42e-05	0.000447	CbGpPWpGaD
Acepromazine—HTR2A—GPCR ligand binding—CXCL8—Crohn's disease	5.4e-05	0.000445	CbGpPWpGaD
Acepromazine—ALB—Metabolism—GPX4—Crohn's disease	5.39e-05	0.000444	CbGpPWpGaD
Acepromazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	5.38e-05	0.000444	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—RBX1—Crohn's disease	5.32e-05	0.000439	CbGpPWpGaD
Acepromazine—SLC22A1—Transmembrane transport of small molecules—ALB—Crohn's disease	5.29e-05	0.000436	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—CXCL8—Crohn's disease	5.29e-05	0.000436	CbGpPWpGaD
Acepromazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	5.27e-05	0.000434	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—RIPK2—Crohn's disease	5.26e-05	0.000434	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—IL2RA—Crohn's disease	5.23e-05	0.000431	CbGpPWpGaD
Acepromazine—ALB—Metabolism—GCKR—Crohn's disease	5.2e-05	0.000429	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—PTGER4—Crohn's disease	5.18e-05	0.000427	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CCR6—Crohn's disease	5.16e-05	0.000426	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—IL3—Crohn's disease	5.13e-05	0.000423	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CCR6—Crohn's disease	5.08e-05	0.000419	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—RBX1—Crohn's disease	5.06e-05	0.000418	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—IL2RA—Crohn's disease	5.05e-05	0.000417	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—IL2RA—Crohn's disease	4.98e-05	0.000411	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—IL2RA—Crohn's disease	4.97e-05	0.00041	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CCR6—Crohn's disease	4.97e-05	0.00041	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—RASGRP1—Crohn's disease	4.96e-05	0.000409	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—PTGER4—Crohn's disease	4.93e-05	0.000407	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—IL2RA—Crohn's disease	4.87e-05	0.000402	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—RBX1—Crohn's disease	4.67e-05	0.000385	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—UBE2D1—Crohn's disease	4.66e-05	0.000385	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—RBX1—Crohn's disease	4.59e-05	0.000379	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—IL2RA—Crohn's disease	4.59e-05	0.000379	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PTGER4—Crohn's disease	4.54e-05	0.000375	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—RIPK2—Crohn's disease	4.52e-05	0.000373	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—IL2RA—Crohn's disease	4.52e-05	0.000373	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—JAK2—Crohn's disease	4.5e-05	0.000371	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—RBX1—Crohn's disease	4.5e-05	0.000371	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—SOCS1—Crohn's disease	4.49e-05	0.000371	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PTGER4—Crohn's disease	4.47e-05	0.000369	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—UBE2D1—Crohn's disease	4.44e-05	0.000366	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—IL2RA—Crohn's disease	4.42e-05	0.000365	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—IL3—Crohn's disease	4.41e-05	0.000364	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PTGER4—Crohn's disease	4.38e-05	0.000361	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—RIPK2—Crohn's disease	4.31e-05	0.000355	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—TYK2—Crohn's disease	4.28e-05	0.000353	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—RASGRP1—Crohn's disease	4.26e-05	0.000352	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—IL3—Crohn's disease	4.2e-05	0.000346	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—CXCL8—Crohn's disease	4.11e-05	0.000339	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—UBE2D1—Crohn's disease	4.09e-05	0.000338	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—JAK2—Crohn's disease	4.09e-05	0.000337	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—RASGRP1—Crohn's disease	4.06e-05	0.000335	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—UBE2D1—Crohn's disease	4.03e-05	0.000332	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—RIPK2—Crohn's disease	3.97e-05	0.000327	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—UBE2D1—Crohn's disease	3.94e-05	0.000325	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—RIPK2—Crohn's disease	3.91e-05	0.000322	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—SMAD3—Crohn's disease	3.88e-05	0.00032	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IL3—Crohn's disease	3.87e-05	0.000319	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—JAK2—Crohn's disease	3.87e-05	0.000319	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—SOCS1—Crohn's disease	3.86e-05	0.000319	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	3.82e-05	0.000315	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IL3—Crohn's disease	3.81e-05	0.000314	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—JAK2—Crohn's disease	3.8e-05	0.000313	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	3.74e-05	0.000309	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—CXCL8—Crohn's disease	3.73e-05	0.000308	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IL3—Crohn's disease	3.73e-05	0.000308	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—JAK2—Crohn's disease	3.69e-05	0.000304	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	3.68e-05	0.000304	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—TYK2—Crohn's disease	3.68e-05	0.000304	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—SOCS1—Crohn's disease	3.68e-05	0.000303	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	3.61e-05	0.000297	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—IL2RA—Crohn's disease	3.59e-05	0.000296	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—CXCL8—Crohn's disease	3.53e-05	0.000291	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—JAK2—Crohn's disease	3.51e-05	0.00029	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—TYK2—Crohn's disease	3.51e-05	0.000289	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	3.4e-05	0.00028	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—SOCS1—Crohn's disease	3.39e-05	0.00028	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—CXCL8—Crohn's disease	3.36e-05	0.000277	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—JAK2—Crohn's disease	3.35e-05	0.000276	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	3.34e-05	0.000276	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	3.34e-05	0.000275	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—SMAD3—Crohn's disease	3.34e-05	0.000275	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	3.27e-05	0.00027	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	3.27e-05	0.00027	CbGpPWpGaD
Acepromazine—ALB—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.25e-05	0.000268	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—TYK2—Crohn's disease	3.23e-05	0.000267	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—CXCL8—Crohn's disease	3.21e-05	0.000265	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	3.18e-05	0.000262	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—SMAD3—Crohn's disease	3.18e-05	0.000262	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	3.12e-05	0.000257	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	3.1e-05	0.000256	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—IL2RA—Crohn's disease	3.09e-05	0.000255	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—JAK2—Crohn's disease	3.09e-05	0.000254	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—CXCL8—Crohn's disease	3.05e-05	0.000252	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	3.05e-05	0.000252	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	3.04e-05	0.00025	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	2.99e-05	0.000246	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	2.97e-05	0.000245	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—IL2RA—Crohn's disease	2.94e-05	0.000243	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—SMAD3—Crohn's disease	2.93e-05	0.000242	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	2.88e-05	0.000238	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	2.82e-05	0.000233	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	2.82e-05	0.000232	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	2.77e-05	0.000229	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	2.71e-05	0.000224	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IL2RA—Crohn's disease	2.71e-05	0.000224	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	2.67e-05	0.00022	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	2.61e-05	0.000215	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—TYK2—Crohn's disease	2.53e-05	0.000209	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—ALB—Crohn's disease	2.48e-05	0.000204	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—JAK2—Crohn's disease	2.41e-05	0.000199	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CXCL8—Crohn's disease	2.2e-05	0.000182	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—TYK2—Crohn's disease	2.18e-05	0.000179	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—PTGS2—Crohn's disease	2.17e-05	0.000179	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—IL6—Crohn's disease	2.1e-05	0.000173	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—JAK2—Crohn's disease	2.08e-05	0.000171	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—TYK2—Crohn's disease	2.07e-05	0.000171	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—JAK2—Crohn's disease	1.98e-05	0.000163	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—TYK2—Crohn's disease	1.91e-05	0.000158	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CXCL8—Crohn's disease	1.89e-05	0.000156	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—TYK2—Crohn's disease	1.88e-05	0.000155	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	1.84e-05	0.000152	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—JAK2—Crohn's disease	1.82e-05	0.00015	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CXCL8—Crohn's disease	1.8e-05	0.000149	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—IL6—Crohn's disease	1.8e-05	0.000149	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—JAK2—Crohn's disease	1.79e-05	0.000148	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—STAT3—Crohn's disease	1.77e-05	0.000146	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	1.76e-05	0.000145	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—IL6—Crohn's disease	1.72e-05	0.000142	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CXCL8—Crohn's disease	1.66e-05	0.000137	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	1.64e-05	0.000135	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	1.6e-05	0.000132	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—IL6—Crohn's disease	1.58e-05	0.00013	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—IL6—Crohn's disease	1.56e-05	0.000128	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	1.52e-05	0.000126	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—STAT3—Crohn's disease	1.52e-05	0.000126	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—STAT3—Crohn's disease	1.45e-05	0.00012	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PTGS2—Crohn's disease	1.45e-05	0.00012	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—STAT3—Crohn's disease	1.34e-05	0.00011	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—STAT3—Crohn's disease	1.32e-05	0.000109	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	1.29e-05	0.000106	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—IL6—Crohn's disease	1.24e-05	0.000102	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—IL6—Crohn's disease	1.06e-05	8.78e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—IL6—Crohn's disease	1.01e-05	8.36e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IL6—Crohn's disease	9.34e-06	7.71e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IL6—Crohn's disease	9.19e-06	7.58e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IL6—Crohn's disease	9e-06	7.42e-05	CbGpPWpGaD
